Filtered By:
Therapy: Cancer Therapy

This page shows you your search results in order of relevance. This is page number 17.

Order by Relevance | Date

Total 4168 results found since Jan 2013.

Erratum: Colony-Stimulating Factors for Febrile Neutropenia during Cancer Therapy
New England Journal of Medicine, Volume 0, Issue 0, Ahead of Print.
Source: New England Journal of Medicine - June 27, 2013 Category: Internal Medicine Tags: article Source Type: research

Cancer therapy: Fueling resistance
Nature Medicine 19, 826 (2013). doi:10.1038/nm.3276 Author: Victoria Aranda
Source: Nature Medicine - July 8, 2013 Category: Journals (General) Authors: Victoria Aranda Tags: Research Highlights Source Type: research

Survival Benefit of Traditional Chinese Herbal Medicine (a Herbal Formula for Invigorating Spleen) for Patients With Advanced Gastric Cancer
Conclusions. TCHM has an important potential value for improving the prognosis of patients with AGC.
Source: Integrative Cancer Therapies - August 27, 2013 Category: Cancer & Oncology Authors: Xu, Y., Zhao, A. G., Li, Z. Y., Zhao, G., Cai, Y., Zhu, X. H., Cao, N. D., Yang, J. K., Zheng, J., Gu, Y., Han, Y. Y., Zhu, Y. J., Yang, J. Z., Gao, F., Wang, Q. Tags: Articles Source Type: research

Breast Cancer Personalized Medicine: Challenges and Opportunities.
Abstract This Guest Editorial introduces this month's special Breast Cancer Theme Issue, a series of reviews that highlight the molecular pathogenesis of breast cancer and implications for personalized breast cancer therapy. PMID: 23978519 [PubMed - as supplied by publisher]
Source: The American Journal of Pathology - August 23, 2013 Category: Pathology Authors: Coleman WB Tags: Am J Pathol Source Type: research

A new gamboge derivative Compound 2 inhibits cancer stem‐like cells via suppressing EGFR tyrosine phosphorylation in head and neck squamous cell carcinoma
In this study, we identified a new gamboge derivative, Compound 2 (C2), which presents eminent suppression effects on cancer cells. Interestingly, when compared with cisplatin (CDDP), C2 effectively suppresses the growth of both cancer stem‐like cells and non‐cancer stem‐like cells derived from head and neck squamous cell carcinoma (HNSCC), inhibiting the formation of tumour spheres and colony in vitro, resulting in the loss of expression of multiple cancer stem cell (CSC)‐related molecules in HNSCC. Treating with C2 effectively inhibited the growth of HNSCC in BALB/C nude mice. Further investigation found that C2 ...
Source: Journal of Cellular and Molecular Medicine - September 23, 2013 Category: Molecular Biology Authors: Rongxin Deng, Xu Wang, Yang Liu, Ming Yan, Sayaka Hanada, Qin Xu, Jianjun Zhang, Zeguang Han, Wantao Chen, Ping Zhang Tags: Original Article Source Type: research

Complementary medicine use among cancer patients receiving radiotherapy and chemotherapy: methods, sources of information and the need for counselling
Complementary medicine (CM) use is common among cancer patients. However, little is known about CM products that are utilised during radiotherapy and/or chemotherapy. Out of 62 cancer patients who completed a specialised survey, 35 (56%) consumed some type of CM during active anti‐cancer therapy. Cancer patients reported the use of herbal teas (52%), vitamins and other dietary supplements (45%), vegetables and juices (39%), special diets (19%), herbal medicines, including Chinese medicines (19%) and ‘immunomodulators’ (3%). Most of patients (86%) consumed CM products every day. However, nearly 47% of CM users did not...
Source: European Journal of Cancer Care - September 1, 2013 Category: Cancer & Oncology Authors: R. Pihlak, R. Liivand, O. Trelin, H. Neissar, I. Peterson, S. Kivistik, K. Lilo, J. Jaal Tags: Original Article Source Type: research

Identification of biomarkers for apoptosis in cancer cell lines using metabolomics: tools for individualized medicine
ConclusionOur observations clearly indicate the potential of metabolomics in detecting metabolic biomarkers applicable in theranostics and for monitoring drug efficacy.
Source: Journal of Internal Medicine - October 16, 2013 Category: Internal Medicine Authors: A. Halama, N. Riesen, G. Möller, M. Hrabě de Angelis, J. Adamski Tags: Review Source Type: research

Adverse Events Associated With Complementary and Alternative Medicine Use in Ovarian Cancer Patients
Conclusion. Although there are concerns about the potential for adverse events related to concurrent use of CAM substances during conventional treatment we found few case reports and clinical trials in the literature which support this.
Source: Integrative Cancer Therapies - October 17, 2013 Category: Cancer & Oncology Authors: Sweet, E. S., Standish, L. J., Goff, B. A., Andersen, M. R. Tags: Articles Source Type: research

BUSM researchers study epigenetic mechanisms of tumor metastasis for improved cancer therapy
(Boston University Medical Center) A review article by researchers at Boston University School of Medicine suggests that epigenetics may be a useful target to stop the growth, spread and relapse of cancer.
Source: EurekAlert! - Medicine and Health - October 30, 2013 Category: Global & Universal Source Type: news

2013 CTRC-AACR San Antonio Breast Cancer Symposium to be held Dec. 10-14
(American Association for Cancer Research) The American Association for Cancer Research, The Cancer Therapy & Research Center at The University of Texas Health Sciences Center at San Antonio, and Baylor College of Medicine will be hosting the 2013 CTRC-AACR San Antonio Breast Cancer Symposium, Dec. 10-14, at the Henry B. Gonzalez Convention Center, San Antonio, Texas.
Source: EurekAlert! - Medicine and Health - November 14, 2013 Category: Global & Universal Source Type: news

Oral mucosal injury caused by cancer therapies: current management and new frontiers in research
Abstract This invited update is designed to provide a summary of the state‐of‐the‐science regarding oral mucosal injury (oral mucositis) caused by conventional and emerging cancer therapies. Current modeling of oral mucositis pathobiology as well as evidence‐based clinical practice guidelines for prevention and treatment of oral mucositis are presented. In addition, studies addressing oral mucositis as published in the Journal of Oral Pathology and Medicine 2008–2013 are specifically highlighted in this context. Key research directions in basic and translational science associated with mucosal toxicity caused by ...
Source: Journal of Oral Pathology and Medicine - November 1, 2013 Category: Pathology Authors: Siri B. Jensen, Douglas E. Peterson Tags: Review Article Source Type: research

Targeted Cancer Therapies Part 1 #276
Journal of Palliative Medicine , Vol. 0, No. 0.
Source: Journal of Palliative Medicine - January 17, 2014 Category: Palliative Care Tags: article Source Type: research

Integrating genomics into clinical oncology: Ethical and social challenges from proponents of personalized medicine
Conclusions: These specific concerns are not unique to oncology, or even genomics. However, those most invested in the success of PM view oncologists' responses to these challenges as precedent setting because oncology is farther along the path of clinical integration of genomic technologies than other fields of medicine. This study illustrates that the rapid emergence of PM approaches in clinical oncology provides a crucial lens for identifying and managing potential frictions and pitfalls that emerge as health care paradigms shift in these directions.
Source: Urologic Oncology: Seminars and Original Investigations - January 21, 2014 Category: Urology & Nephrology Authors: Michelle L. McGowan, Richard A. Settersten, Eric T. Juengst, Jennifer R. Fishman Tags: Seminar Articles Source Type: research

Targeted Cancer Therapies, Part 2 #277
Journal of Palliative Medicine , Vol. 0, No. 0.
Source: Journal of Palliative Medicine - February 14, 2014 Category: Palliative Care Tags: article Source Type: research

Turmerones enhanced anti-proliferative activities of curcumin in human colonic cancer cells and endothelial cells
In conclusion, our study reported for the first time the superior anti-proliferative activities of curcumin plus turmerones than curcumin alone in human colonic cancer cells and endothelial cells. Together with modulation of absorption by turmerones, the use of curcumin plus turmerones may lead to more benefits in cancer therapy.
Source: European Journal of Integrative Medicine - February 1, 2014 Category: Complementary Medicine Authors: Grace G.L. Yue, Lei Jiang, Carmen K.M. Chan, Eric C.W. Wong, Kwok-Pui Fung, Ping-Chung Leung, Clara B.S. Lau Tags: Abstracts Source Type: research